De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis
De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis
Recruiting · NCT07303686 · Registry updated 2025-12-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 4 | 2025-12-26 | NCT07303686 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Inc. | 6 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 139 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MUHC - Montreal General Hospital | Montreal | Canada | 1 |